Rothfuss Cristin 4

What Happened
Cristin Rothfuss, EVP and General Counsel of Sarepta Therapeutics (SRPT), had 974 shares withheld/disposed on March 11, 2026 to satisfy tax withholding obligations. The withholding was recorded at $17.03 per share, for a total value of approximately $16,587. This was a tax-withholding disposition tied to restricted stock unit (RSU) vesting, not an open-market sale or purchase.

Key Details

• Transaction date and price: 2026-03-11, 974 shares @ $17.03 ($16,587 total).
• Shares owned after transaction: Not specified in the provided excerpt of the Form 4 (see full filing for total holdings).
• Footnote: F1 — shares were withheld by the company to satisfy tax withholding obligations related to vesting of RSUs granted on March 10, 2025.
• Filing timeliness: Form 4 filed 2026-03-13 — appears timely (within the standard 2-business-day reporting window).
• Transaction code: F (payment of exercise price or tax liability / shares withheld).

Context
This was a routine tax-withholding event associated with RSU vesting. Such withholdings reduce the insider’s reported shares but are not the same as an open-market sale and generally don’t signal a deliberate trading decision.